Connect with us
[the_ad id="89560"]

Health

Dad says 5-year-old develops autism after being forced to get 18 vaccines in 1 day

Published

18 minute read

From LifeSiteNews

By Michael Nevradakis Ph. D., The Defender

As part of a custody battle, a Tennessee judge ordered a family to vaccinate all three of their children, all of whom had never been vaccinated. Five-year-old Isaac immediately became ill and was eventually diagnosed with severe regressive autism.

In 2016, David Ihben moved his wife and three children from Chicago to Jamestown, in rural Tennessee, with high hopes for a new and calmer life.

But the dream turned into a nightmare for David and his children in December 2019, when divorce proceedings and a subsequent custody battle resulted in the forced vaccination of the children – and changed the family’s fortunes forever.

Ihben said his ex-wife decided “this wasn’t the life she wanted.” So they were attempting to develop a parenting plan in family court – when Tennessee judge Todd Burnett “pulled up the vaccine issue” after discovering the couple’s children were unvaccinated – and forced the parents to vaccinate their children.

Ihben’s two oldest children – daughter Hannah and son Joseph – were spared significant adverse events following their vaccination.

But his youngest son, Isaac, wasn’t so fortunate. After receiving 18 vaccines in one day, Isaac developed severe regressive autism. Today, he requires around-the-clock care.

The children’s mother soon abandoned the children, leaving Ihben to raise them as a single parent – even though he is still obliged to pay child support.

‘How can a judge force medical care without a doctor’s input?’

Ihben told The Defender his entire family was unvaccinated. “I’ve never had any. My dad was drafted by the Army in 1961, and he didn’t get any either. We’ve never vaccinated,” he said. “Our children had to sign religious exemptions for school.”

During divorce proceedings though, his wife’s attorney used the vaccination issue to drive a wedge between the parents.

“When we went to court, I guess her attorney knew that [Burnett] was a pro-vaccine judge and that’s something that they could get me on,” Ihben said.

According to Ihben, Burnett told the couple that it was his “personal opinion that not vaccinating your children is child abuse.” He then told the couple that whichever parent would be willing to vaccinate the children that same day would leave the courthouse with custody.

“I said, ‘Your Honor, we have rights. It’s between the mom and their father,’” Ihben recalled. “Her attorney whispered to her, and she goes, ‘I’ll take them down and vaccinate them today.’”

“I was so surprised, because me and my ex-wife didn’t agree on much, but we did agree on that,” Ihben said, referring to their views on vaccination.

After the hearing, Ihben and his wife were granted joint custody of the children, with their mother as their primary guardian. Later that day, the children received their childhood vaccines – and Isaac immediately became sick.

“My daughter had previous allergies … so the doctor refused to give her all in one day. They split those … She didn’t have any side effects from what I can see,” Ihben said. “[Joseph] was in the ICU for a couple of days but seems to be okay. But [Isaac] spent 12 days in the ICU, eight days with a 106-degree fever.”

Isaac, who was 5 years old at the time, was “just a normal happy kid,” Ihben said.

Today, Isaac has severe regressive autism. Ihben told The Defender:

“He doesn’t talk. He wears a diaper. He eats out of a baby bottle 20-30 times a day, he has speech therapy and will require 24-hour care and supervision for the rest of his life.

“I haven’t had a full night’s sleep in four years. He has to be changed every two hours, or he will have an accident. If you have a child with regressive autism or know someone, you will understand what our days are like.”

Ihben didn’t learn about Isaac’s injuries right away, because the court initially slapped him with a six-month restraining order. When the six months were up, he finally made plans to pick up his children for “two-hour supervised visitation” at a local McDonald’s.

“My youngest comes walking out and I’m like, ‘What’s going on?’” He said his oldest children then told him about what happened to Isaac. “My children told me everything that’s going on. Basically, nobody’s given me information. I had to go off what 10- and 11-year-olds were telling me,” Ihben said.

Ihben tried to find out what happened to Isaac – but encountered more obstacles at Cookeville Regional Medical Center, his local hospital. “The judge had sealed the hospital records. I still cannot get them,” he said.

It wasn’t until he enrolled his daughter in high school that, while obtaining her records from the local health department, he had a chance to view Isaac’s records. That’s when he saw that Isaac had received 18 vaccines in one day.

“How can a judge force medical care without a doctor’s input?” Ihben asked. “I don’t think judges should be dictating medical treatment from the bench.”

According to Ihben, doctors at Vanderbilt University in Nashville said Isaac’s injuries “are a direct result from forced vaccination,” with one doctor telling Ihben that “she’s seen only one other kid that acts like Isaac does.”

Required to continue paying child support, despite mother’s disappearance

Soon after seeing his children for the first time after the custody battle, another surprise was in store for Ihben and his family: Ihben’s ex-wife called to say she and the children had been evicted.

After he kept the children for a week, their mother “got a free house, everything furnished and paid,” and the children were returned to her.

“Then she got evicted from there” in May 2020, Ihben said. He again picked up the children – but that was the last they saw of their mother. According to Ihben, after her second eviction, she left town without a trace.

“We haven’t heard from her or seen her,” Ihben said. “It’ll be five years in May.”

Ihben still pays child support to the state, even though he alone takes care of the children. He said the child support money, which remains uncollected, goes to a state fund – and, if it remains unclaimed, will be confiscated by the state when the children reach adulthood.

Ihben said that though he has gone to court to request full custody of his children or a reduction of his child support payments, he has faced a catch-22 situation.

“The judge said, I can’t do anything unless you get her here in front of me,” Ihben said. “I was like, ‘I’ve served her. Nobody knows where she is.’”

Ihben said he believes the children’s mother didn’t realize Isaac was going to be hurt so badly, and “she just can’t face it.” He added, “I just don’t understand, if she’s been gone almost five years, why she still has full custody, why I still have to pay child support.”

Tennessee laws, local officials pose challenges for raising Isaac

Ihben described the day-to-day realities of caring for Isaac, who will turn 11 next month and just started the fifth grade in a special education program. He said:

“Our lives have changed forever. I can’t have a regular job. I pick up stuff here and there … I have an alarm that goes off every two hours to change Isaac. He eats in the middle of the night … We live out in the country. There’s no bus, so I take him to school back and forth.

“He doesn’t talk, so you don’t know if he’s sick, if he’s upset, if he’s hungry, if he’s cold, if he has a stomach ache … I’ve got a mental list, and I just check it off and hopefully I hit the one that calms him and provides what he needs.”

State rules also pose obstacles. “You’re not allowed to have home healthcare for a disabled child unless you have no other children in the home under 18,” Ihben said.

Ihben noted that Tennessee ranks among the states with the lowest level of funding for autistic children, adding that autistic children are frequently mistreated.

“Our local school district has restraint chairs for autistic children. They are allowed to put Isaac in a chair, to pepper spray him, to tase him. Police departments have no training for dealing with autistic children,” Ihben said.

Ihben said state, county and town officials have attempted to intimidate him and his family.

According to Ihben, the Tennessee Bureau of Investigation (TBI) showed up at his home on Dec. 5, 2023. “Somebody starts beating on the door … there’s a truck at the end of the road, a truck at the end of the other road and two trucks in the driveway. They had assault weapons.”

Ihben said the officers claimed that a social worker wanted to speak with him, but that he refused to open his door for them. He submitted a Freedom of Information Act request to the state to find out why his home was raided, but was told there are “no records of anything.”

The TBI raid took a toll on him. “I had a heart attack that night,” he said. “I couldn’t breathe.” He said the incident still affects him today. “I’m sure I have PTSD from it. I’m still under treatment,” Ihben said.

In June 2023, Ihben said he went to his county commission meeting to tell them about what happened to his family. The county commissioner, Jimmy Johnson, left him a voicemail warning him not to hold any rally or protest.

“The commissioner called the sheriff,” Ihben said, but ultimately “they backed off.”

In another incident, Ihben said he was banned from his local Walmart store after a store manager called the police because Isaac “was causing a disturbance.” This obliged Ihben to shop at another Walmart, an hour away from his home.

Ihben said it’s also difficult to find a lawyer to represent him and his family. “No attorney is willing to take on the judge.”

Local officials ‘tried to scare us’ into not doing Vax-Unvax bus interview

Ihben credited CHD and its Tennessee Chapter for helping him and his family. “We wouldn’t be here without CHD helping us out,” Ihben said. “The Tennessee Chapter has helped us out a lot.”

Ihben said he recently saw “Vaxxed 3” with members of the state’s CHD chapter. “What we have to live through every day is horrible, but it could be worse,” Ihben said, citing stories in the film of children who died post-vaccination.

According to Ihben, his efforts to promote CHD initiatives in his community, such as the visit of the Vax-Unvax bus earlier this year, have also been met with intimidation.

“We put a little flyer together [for the Vax-Unvax bus] and we started passing it out,” Ihben said. But on Feb. 1, the day of his bus interview, Ihben said his wife’s attorney, her husband – who is the attorney for the local school board – and Burnett, who mobilized the TBI, “tried to scare us into not doing the bus interview.”

Getting the word out, spreading the message is ‘the only weapon we have’

Isaac has recently shown some improvement, according to Ihben. “He’s doing better slowly … He’s in a lot of therapy. He’s starting to write some numbers and letters on his own. Teachers think he’s reading, but he’s still never said a word.”

Ihben said this has been a learning experience for his oldest children, who will “have to take care of Isaac every day” after his death. “That’s a lifetime commitment.”

Another silver lining, according to Ihben, is that Isaac’s story has become a learning experience for his family and many members of his local community.

“This hasn’t just got me learning. My kids are learning. Hannah and Joseph are learning about their government and their food and their environment. They’re teaching their friends about this.”

For Ihben, getting the word out and spreading the message is “the only weapon we have.” He said, “It’s powerful that my kids’ friends come up and say ‘we’re sorry for what happened to you, we’ve seen the [Vax-Unvax] interview.’”

Ihben said he hopes the message will help other children avoid Isaac’s fate. “I hope Isaac will be the last,” he said.

This article was originally published by The Defender – Children’s Health Defense’s News & Views Website under Creative Commons license CC BY-NC-ND 4.0. Please consider subscribing to The Defender or donating to Children’s Health Defense.

Break The Needle

Why psychedelic therapy is stuck in the waiting room

Published on

By Alexandra Keeler 

There is mounting evidence of psychedelics’ effectiveness at treating mental disorders. But researchers face obstacles conducting rigorous studies

In a move that made international headlines, America’s top drug regulator denied approval last year for psychedelic-assisted therapy to treat post-traumatic stress disorder.

In its decision, the U.S. Food and Drug Administration cited concerns about study design and inadequate evidence to assess the benefits and harms of using the drug MDMA.

The decision was a significant setback for psychedelics researchers and veterans’ groups who had been advocating for the therapy to be approved. It is also reflective of a broader challenge faced by researchers keen to validate the therapeutic potential of psychedelics.

“Sometimes I feel like it’s death by 1,000 paper cuts,” said Leah Mayo, a researcher at the University of Calgary.

“If the regulatory burden were a little bit less, that would be helpful,” added Mayo, who holds the Parker Psychedelics Research Chair at the Psychedelic and Cannabinoid Therapeutics Lab. The lab develops new treatments for mental health disorders using psychedelics and cannabinoids.

Sources say the weak research body behind psychedelics is due to a complex interplay of factors. But they would like to see more research conducted to make psychedelics more accessible to people who could benefit from them.

“If you want [psychedelics] to work within existing health-care infrastructure, you have to play by [Canadian research] rules,” said Mayo.

“Therapy has to be reproducible, it has to be evidence-based, it has to be grounded in reality.”

Psychedelics in Canada

Psychedelics are hallucinogenic substances such as psilocybin, MDMA and ketamine that alter people’s perceptions, mood and thought processes. Psychedelic therapy involves the use of psychedelics in guided sessions with therapists to treat mental health conditions.

Psychedelics are generally banned for possession, production and distribution in Canada. However, two per cent of Canadians consumed hallucinogens in 2019, according to the latest Canadian Alcohol and Drugs Survey. Psychedelics are also used in Canada and abroad in unregulated clinics and settings to treat conditions such as substance use disorderpost-traumatic stress disorder (PTSD) and various mental disorders.

“The cat’s out of the bag, and people are using this,” said Zachary Walsh, a professor in the Department of Psychology at the University of British Columbia.

Within Canada, there are three ways for psychedelics to be accessed legally.

The federal health minister can approve their use for medical, scientific or public interest purposes. Health Canada runs a Special Access Program that allows doctors to request the use of unapproved drugs for patients with serious conditions that have not responded to other treatments. And Health Canada can approve psychedelics for use in clinical trials.

Researchers interested in conducting clinical trials involving psychedelics face significant hurdles.

“There’s been a concerted effort — and it’s just fading now — to mischaracterize the risks of these substances,” said Walsh, who has conducted several studies on the therapeutic uses of psychedelics. These include studies on MDMA-assisted therapy for PTSD, and the effects of microdosing psilocybin on stress, anxiety and depression.

 

This Substack is reader-supported.

To receive new posts and support my work, consider becoming a free or paid subscriber.

 

The U.S. government demonized psychedelic substances during its War on Drugs in the 1970s, exaggerating their risks and blocking research into their medical potential. Influenced by this war, Canada adopted similar tough-on-drugs policies and restricted research.

Today, younger researchers are pushing forward.

“New ideas really come into the forefront when the people in charge of the old ideas retire and die,” said Norman Farb, an associate professor in the Department of Psychology at the University of Toronto.

But it remains a challenge to secure funding for psychedelic research. Government funding is limited, and pharmaceutical companies are often hesitant to invest because psychedelic-assisted therapy does not generally fit the traditional pharmaceutical model.

“It’s not something that a pharmaceutical company wants to pay for, because it’s not going to be a classic pharmaceutical,” said Walsh.

As a result, many researchers rely on private donations or venture capital. This makes it difficult to fund large-scale studies, says Farb, who has faced institutional obstacles researching microdosing for treatment-resistant depression.

“No one wants to be that first cautionary tale,” he said. “No one wants to invest a lot of money to do the kind of study that would be transparent if it didn’t work.”

Difficulties in clinical trials

But funding is not the only challenge. Sources also pointed to the difficulty of designing clinical trials for psychedelics.

In particular, it can be difficult to implement a blind trial process, given the potent effects of psychedelics. Double blind trials are the gold standard of clinical trials, where neither the person administering the drug or patient knows if the patient is receiving the active drug or placebo.

Health Canada also requires researchers to meet strict trial criteria, such as demonstrating that the benefits outweigh the risks, that the drug treats an ongoing condition with no other approved treatments, and that the drug’s effects exceed any placebo effect.

It is especially difficult to isolate the effects of psychedelics. Psychotherapy, for example, can play a crucial role in treatment, making it difficult to disentangle the role of therapy from the drugs.

Mayo, of the University of Calgary, worries the demands of clinical trial models are not practical given the limitations of Canada’s health-care system.

“The way we’re writing these clinical trials, it’s not possible within our existing health-care infrastructure,” she said. She cited as one example the expectation that psychiatrists in clinical trials spend eight or more hours with each patient.

Ethical issues

Psychedelics research can also raise ethical concerns, particularly where it involves individuals with pre-existing mental health conditions.

A 2024 study found that people who visited an emergency room after using hallucinogens were at a significantly increased risk of developing schizophrenia — raising concerns that trials could harm vulnerable participants.

Another problem is a lack of standardization in psychedelic therapy. “We haven’t standardized it,” said Mayo. “We don’t even know what people are being taught psychedelic therapy is.”

This concern was underscored in a 2015 clinical trial on MDMA in Canada, where one of the trial participants was subjected to inappropriate physical contact and questioning by two unlicensed therapists.

Mayo advocates for the creation of a regulatory body to standardize therapist training and prevent misconduct.

Others have raised concerns about whether the research exploits Indigenous knowledge or cultural practices.

“There’s no psychedelic science without Indigenous communities,” said Joseph Mays, a doctorate candidate at the University of Saskatchewan.

“Whether it’s medicalized or ceremonial, there’s a direct continuity with Indigenous practices.”

Mays is an advisor to the Indigenous Reciprocity Initiative, which funnels psychedelic investments back to Indigenous communities. He believes those working with psychedelics must incorporate reciprocity into their work.

“If you’re using psychedelics in any way, it only makes sense that you would also have a commitment to fighting for the rights of [Indigenous] communities, which are still lacking basic necessities,” said Mays, suggesting that companies profiting from psychedelic medicine should contribute to Indigenous causes.

Despite these various challenges, sources remained optimistic that psychedelics would eventually be legalized — although not due to their work.

“It’s inevitable,” said Mays. “They’re already widespread, being used underground.”

Farb agrees. “A couple more research studies is not going to change the law,” he said. “Power is going to change the law.”


This article was produced through the Breaking Needles Fellowship Program, which provided a grant to Canadian Affairs, a digital media outlet, to fund journalism exploring addiction and crime in Canada. Articles produced through the Fellowship are co-published by Break The Needle and Canadian Affairs.

Subscribe to Break The Needle.

Our content is always free – but if you want to help us commission more high-quality journalism, consider getting a voluntary paid subscription.

Continue Reading

Addictions

There’s No Such Thing as a “Safer Supply” of Drugs

Published on

By Adam Zivo

Sweden, the U.K., and Canada all experimented with providing opioids to addicts. The results were disastrous.

[This article was originally published in City Journal, a public policy magazine and website published by the Manhattan Institute for Policy Research. We encourage our readers to subscribe to them for high-quality analysis on urban issues]

Last August, Denver’s city council passed a proclamation endorsing radical “harm reduction” strategies to address the drug crisis. Among these was “safer supply,” the idea that the government should give drug users their drug of choice, for free. Safer supply is a popular idea among drug-reform activists. But other countries have already tested this experiment and seen disastrous results, including more addiction, crime, and overdose deaths. It would be foolish to follow their example.

The safer-supply movement maintains that drug-related overdoses, infections, and deaths are driven by the unpredictability of the black market, where drugs are inconsistently dosed and often adulterated with other toxic substances. With ultra-potent opioids like fentanyl, even minor dosing errors can prove fatal. Drug contaminants, which dealers use to provide a stronger high at a lower cost, can be just as deadly and potentially disfiguring.

Because of this, harm-reduction activists sometimes argue that governments should provide a free supply of unadulterated, “safe” drugs to get users to abandon the dangerous street supply. Or they say that such drugs should be sold in a controlled manner, like alcohol or cannabis—an endorsement of partial or total drug legalization.

But “safe” is a relative term: the drugs championed by these activists include pharmaceutical-grade fentanyl, hydromorphone (an opioid as potent as heroin), and prescription meth. Though less risky than their illicit alternatives, these drugs are still profoundly dangerous.

The theory behind safer supply is not entirely unreasonable, but in every country that has tried it, implementation has led to increased suffering and addiction. In Europe, only Sweden and the U.K. have tested safer supply, both in the 1960s. The Swedish model gave more than 100 addicts nearly unlimited access through their doctors to prescriptions for morphine and amphetamines, with no expectations of supervised consumption. Recipients mostly sold their free drugs on the black market, often through a network of “satellite patients” (addicts who purchased prescribed drugs). This led to an explosion of addiction and public disorder.

Most doctors quickly abandoned the experiment, and it was shut down after just two years and several high-profile overdose deaths, including that of a 17-year-old girl. Media coverage portrayed safer supply as a generational medical scandal and noted that the British, after experiencing similar problems, also abandoned their experiment.

While the U.S. has never formally adopted a safer-supply policy, it experienced something functionally similar during the OxyContin crisis of the 2000s. At the time, access to the powerful opioid was virtually unrestricted in many parts of North America. Addicts turned to pharmacies for an easy fix and often sold or traded their extra pills for a quick buck. Unscrupulous “pill mills” handed out prescriptions like candy, flooding communities with OxyContin and similar narcotics. The result was a devastating opioid epidemic—one that rages to this day, at a cumulative cost of hundreds of thousands of American lives. Canada was similarly affected.

The OxyContin crisis explains why many experienced addiction experts were aghast when Canada greatly expanded access to safer supply in 2020, following a four-year pilot project. They worried that the mistakes of the recent past were being made all over again, and that the recently vanquished pill mills had returned under the cloak of “harm reduction.”

Subscribe for free to get BTN’s latest news and analysis – or donate to our investigative journalism fund.

Most Canadian safer-supply prescribers dispense large quantities of hydromorphone with little to no supervised consumption. Patients can receive up to 40 eight-milligram pills per day—despite the fact that just two or three are enough to cause an overdose in someone without opioid tolerance. Some prescribers also provide supplementary fentanyl, oxycodone, or stimulants.

Unfortunately, many safer-supply patients sell or trade a significant portion of these drugs—primarily hydromorphone—in order to purchase more potent illicit substances, such as street fentanyl.

The problems with safer supply entered Canada’s consciousness in mid-2023, through an investigative report I wrote for the National Post. I interviewed 14 addiction physicians from across the country, who testified that safer-supply diversion is ubiquitous; that the street price of hydromorphone collapsed by up to 95 percent in communities where safer supply is available; that youth are consuming and becoming addicted to diverted safer-supply drugs; and that organized crime traffics these drugs.

Facing pushback, I interviewed former drug users, who estimated that roughly 80 percent of the safer-supply drugs flowing through their social circles was getting diverted. I documented dozens of examples of safer-supply trafficking online, representing tens of thousands of pills. I spoke with youth who had developed addictions from diverted safer supply and adults who had purchased thousands of such pills.

After months of public queries, the police department of London, Ontario—where safer supply was first piloted—revealed last summer that annual hydromorphone seizures rose over 3,000 percent between 2019 and 2023. The department later held a press conference warning that gangs clearly traffic safer supply. The police departments of two nearby midsize cities also saw their post-2019 hydromorphone seizures increase more than 1,000 percent.

The Canadian government quietly dropped its support for safer supply last year, cutting funding for many of its pilot programs. The province of British Columbia (the nexus of the harm-reduction movement) finally pulled back support last month, after a leaked presentation confirmed that safer-supply drugs are getting sold internationally and that the government is investigating 60 pharmacies for paying kickbacks to safer-supply patients. For now, all safer-supply drugs dispensed within the province must be consumed under supervision.

Harm-reduction activists have insisted that no hard evidence exists of widespread diversion of safer-supply drugs, but this is only because they refuse to study the issue. Most “studies” supporting safer supply are produced by ideologically driven activist-scholars, who tend to interview a small number of program enrollees. These activists also reject attempts to track diversion as “stigmatizing.”

The experiences of Sweden, the United Kingdom, and Canada offer a clear warning: safer supply is a reliably harmful policy. The outcomes speak for themselves—rising addiction, diversion, and little evidence of long-term benefit.

As the debate unfolds in the United States, policymakers would do well to learn from these failures. Americans should not be made to endure the consequences of a policy already discredited abroad simply because progressive leaders choose to ignore the record. The question now is whether we will repeat others’ mistakes—or chart a more responsible course.

Our content is always free –

but if you want to help us commission more high-quality journalism,

consider getting a voluntary paid subscription.

Continue Reading

Trending

X